The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000257.3(MYH7):c.2539_2541delAAG (p.Lys847del)

CA012568

42913 (ClinVar)

Gene: MYH7
Condition: hypertrophic cardiomyopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 58966d39-7dea-41df-be75-5371df18e99e
Approved on: 2021-10-05
Published on: 2021-10-05

HGVS expressions

NM_000257.3(MYH7):c.2539_2541delAAG (p.Lys847del)
ENST00000355349.4:c.2539_2541del
ENST00000355349.3:c.2539_2541del
NM_000257.3:c.2539_2541del
NM_000257.4:c.2539_2541del
NC_000014.9:g.23424909_23424911del
CM000676.2:g.23424909_23424911del
NC_000014.8:g.23894118_23894120del
CM000676.1:g.23894118_23894120del
NC_000014.7:g.22963958_22963960del
NG_007884.1:g.15753_15755del

Likely Pathogenic

Met criteria codes 4
PM2 PM4_Supporting PS4 PP1
Not Met criteria codes 9
PM6 BS3 BS1 BP3 BP5 BP2 PS3 PS2 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cardiomyopathy VCEP
The NM_000257.4: c.2539_2541del (p.Lys847del) variant in MYH7 has been reported in >15 individuals with HCM (PS4; Van Driest 2004 PMID:15358028; Santos 2012 PMID:22429680; Kassem 2013 PMID:23233322; Marsiglia 2013 PMID:24093860; Waldmuller 2008 PMID:18258667; Walsh 2017 PMID: 27532257; Ho 2018 PMID: 30297972; Jaaskelainen 2019 PMID: 30775854; LMM pers. comm.; Invitae pers. comm.). This variant segregated with disease in 3 affected individuals with HCM from 2 families(PP1; LMM pers. comm.). This variant was absent from large population studies (PM2; gnomAD v.2.1.1, http://exac.broadinstitute.org,). This variant is a deletion of 1 amino acid at position 847 and is not predicted to alter the protein reading-frame. Given that only 1 amino acid has been deleted, the expert panel felt that adjusting to supporting evidence would be more appropriate in this case (PM4_Supporting). In summary, this variant meets criteria to be classified as likely pathogenic for hypertrophic cardiomyopathy in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (Kelly 2018 PMID:29300372): PS4; PP1; PM2; PM4_Supporting.
Met criteria codes
PM2
Absent from gnomad with good coverage
PM4_Supporting
In-frame indel of one aa
PS4
>15 probands with HCM. There are more publications, but did not continue
PP1
3 segregations from LMM, 2 families
Not Met criteria codes
PM6
n/a
BS3
none available
BS1
Absent from gnomad with good coverage
BP3
In-frame indel in a non-repeat region
BP5
not oberved
BP2
not observed
PS3
none available
PS2
n/a
BA1
Absent from gnomad with good coverage
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.